Product Images Methylphenidate Hydrochloride

The text describes a medication called Methylphenidate Hydrochloride Extended-Release Tablets. The tablets contain 15mg met ganlalecreleass ormuiation and are meant to be taken once daily. The medication is packaged in a bottle with 30 tablets (3 x 10) and requires a prescription. The accompanying medication guide should be dispensed to each patient. The tablets should be stored at a temperature of 20 to 25°C (63 to 77°F) and protected from humidity. The drugs should be kept away from children, and the package should not be used if it is torn or broken. The medication is produced by Camoor Pharmacoteas and distributed by American Health Packaging in Columbus, Ohio.*

NDC 60687-543-21 is Methylphenidate Hydrochloride, an extended-release tablet used for treating ADHD. The recommended dosage is one tablet per day, and it should be stored in controlled room temperature conditions to protect it from humidity. Patients should keep the drug out of reach of children, and it should not be used if the packaging is damaged. The product is manufactured by Camoer Pharmeseunicais and distributed by American Health Packaging.*

This is a description of a medication containing Methylphenidate Hydrochloride in extended-release tablet form. It is available in a 36 mg strength and is sold in a package of 30 tablets. The package is RX-only and includes instructions for use and storage. The product is manufactured and distributed by American Teva Packaging in Columbus, Ohio.*

This is a package of Methylphenidate Hydrochloride Extended-Release Tablets, USP, which contains 30 tablets in total. The tablets are for oral consumption, and each of them contains 52g of methylphenidate hydrochloride. The usual dosage is mentioned to be once daily and the information can be found on the package insert. The tablets need to be stored between 20 to 25 degrees Celsius and protected from humidity. The product is manufactured by K V Pharmaceuticals and has been packaged and distributed by American Fast Packaging. DEA Order Form is required to use the drug product.*

This is a table showing the mean plasma concentration of methylphenidate in nanograms per milliliter. The concentration is measured after the oral administration of extended-release methylphenidate hydrochloride tablets at a dosage of 18mg once daily or immediate-release methylphenidate at a dosage of 5mg or 15mg three times daily.*

This text appears to be a form or table related to a study of the symptoms of inattention and overactivity related to the administration of Methylphenidate Hydrochloride tablets. The form compares the results of three separate studies (Study1, Study2, Study3) using a scale (not visible in the provided text) to evaluate the presence and severity of these symptoms. The text also shows that Methylphenidate Hydrochloride was administered in the form of 15 extended-release tablets once per day, and a placebo was also included for comparison. The last line of text may indicate the duration of the study, possibly one week ("ek"?).*